January 2018
Cummings Issues Statement on President's
Comments on Drug Prices During State of the Union
Washington, D.C. (Jan. 31, 2018)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement in response to President Donald Trump's comments during the State of the Union Address regarding the skyrocketing prices of prescription drugs:
ENGEL & CUMMINGS TO STATE DEPT. INSPECTOR: ADDRESS ALLEGED POLITICAL RETRIBUTION AGAINST CAREER EMPLOYEES |
Cummings and Connolly Ask
Gowdy to Subpoena Documents on
HHS Gag Order Against Whistleblowers
Oversight Dems Ask Gowdy to Subpoena
Documents Withheld by Trump Administration on
Russian Attacks on 21 States in 2016 Election
Top Dems to AG Sessions, Secretary Nielsen: Flawed and Misleading Report is a Blatant Political Attempt to Link Immigration & Terrorism
Cummings and Gomez Question Bank of America's
Decision to Terminate No-Fee Checking Accounts
Right After Receiving Massive Tax Windfall
SCHATZ, CUMMINGS, YOUNG INTRODUCE BILL TO ESTABLISH NATIONAL COUNCIL ON FEDERAL LABOR-MANAGEMENT RELATIONS
Bipartisan Bill Reinstitutes Decades-Old Panels Used for Dialogues Between Federal Workers and Federal Agency Management
GAO Adds Security Clearance Process to
Urgent List of "High Risk" Programs
Confirms Repeated Concerns from Ranking Member Cummings,
Who Again Calls on Gowdy to Subpoena Documents Being Withheld
NADLER & CUMMINGS URGE DOJ IG TO INVESTIGATE ATTEMPTS TO DISCREDIT FBI INVESTIGATORS & WEAKEN FBI INDEPENDENCE
Cummings Asks Gowdy to Subpoena
White House for Documents Withheld on
Interim Security Clearances
New Pentagon Data Highlights
"Critical Failings" in Interim Clearance Process;
Questions About Kushner's Clearance Multiply